
The U.S. Courts of Appeal Have Been Busy: Top Health Care Fraud Decisions of 2025 (so far)
Hosted by By Polsinelli PC
Location, or Event type: Webinar
The U.S. Courts of Appeal Have Been Busy: Top Health Care Fraud Decisions of 2025 (so far)
Webinar, Hosted By Polsinelli PC
Date: Thu, Jul 10, 2025- 12:00 PM
The Federal appellate courts have weighed in on a number of interesting health care fraud and abuse issues in early 2025. Polsinelli has pulled together a panel of lawyers who actively litigate health care matters to discuss the top five court opinions that could affect your business.
*CLE Credit Pending
Agenda Topics:
The panel plans to discuss the following cases:
United States v Sorensen (7th Cir.)
- Analyzing the scope of the Federal Anti-Kickback Statute (“AKS”) including what is a “referral” in the sales and marketing context
United States ex rel Vanderlan v Jackson HMA (5th Cir.)
- Discussing the government’s ability to dismiss qui tam actions over relator objections
United States v Hall (5th Cir.)
- Ruling on the burden of proof when compliance with the AKS is based upon compliance with a safe harbor and the scope of the employment safe harbor
United States v Regeneron Pharmaceuticals, (128 F.4th 324, 1st Cir.)
- Weighing-in on the contentious issue of causation for False Claims Act damages based upon alleged AKS violations
Pharmaceutical Coalition for Patient Access v United States, 126 F.4th 947 (4th Cir.)
- Discussing the application of the AKS to benefits given to beneficiaries in a challenge to an HHS Office of the Inspector General advisory opinion